caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1821040320

Jonathan TerdimanMD

GastroenterologySan Francisco, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jonathan Terdiman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Soo-Jin Cho
Pathology · San Francisco, CA
2656
Gordon Fung
Cardiology · San Francisco, CA
2289
Kimberley Evason
Pathology · San Francisco, CA
1941
Grace Kim
Pathology · San Francisco, CA
1733
Kuang-Yu Jen
Pathology · Sacramento, CA
1632
NPI 14476823801541
Sanjay Kakar
Pathology · San Francisco, CA
1430
Tatyana Chursina
Physician Assistant · Sacramento, CA
1441
Ucsf Dermatopathology Service
Clinical Laboratory · San Francisco, CA
1122
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
589
Unique beneficiaries
—
Total services
653
Distinct HCPCS
12
Medicare payment
$69K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,398 Gastroenterology providers in CA — top quintile (cohort median 750).
PRESCRIBING · PART D · 2024
Total Rx claims
294
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
14
Brand share
65.6%
Top prescribed drugs
Sodium Chloride 0.45 %53 claims
Pantoprazole Sodium24 claims
Risankizumab-Rzaa23 claims
Rifaximin21 claims
Omeprazole20 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
81.1
Cost
71.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$51
Payment records
1
By payment type
Food and Beverage$51